Axitinib inlyta fda approval date 2012?

When was Inlyta (axitinib) approved by the FDA?

Inlyta (axitinib) received FDA approval in 2012. [1]

What FDA approval happened in 2012?

The 2012 approval refers to Inlyta’s FDA approval for use in advanced renal cell carcinoma (RCC). [1]

What label does that approval cover?

FDA materials for Inlyta list the drug and its approval in 2012, with the indication focused on advanced renal cell carcinoma. [1]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202457